Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases

Asian Journal of Transfusion Science

Volumn 6, Issue 1, 2012, Pages 24-28

  Gad, Yahia Z ^a   Mouas, Narres ^a   Abdel Aziz, Azza ^a   Abousmra, Nashwa ^a   Elhadidy, Mona ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cytokines; Hepatitis C virus; occult

Indexed keywords

EID: 84879193431     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.95046     Document Type: Article

References (43)

1. Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al. HCV infection: pathogenesis, clinical manifestations, and therapy. Clin Exp Rheumatol 2008;26 Suppl 48:S39-47. (Pubitemid 351578094)
2. Chen SL, Morgan TR. The natural history of hepatitis C virus infection. Int J Med Sci 2006;3:47-52.
3. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36 Suppl 1:S35-46. (Pubitemid 35253462)
4. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, de Lucas S, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004;189:7-14. (Pubitemid 38122323)
5. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-40. (Pubitemid 26181213)
6. Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Castillo I, Carreño V. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 2007;14:36-40. (Pubitemid 46012359)
7. Tilg H, Kaser A, Moschen AR. How to modulate inflammatory cytokines in liver diseases. Liver Int 2006;26:1029-39. (Pubitemid 44541743)
8. Napoli J, Bishop A, Mc Guinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intra-hepatic expression of Th1-associated cytokines. Hepatology 1996;24:759-65. (Pubitemid 26334270)
9. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997;25:449-57.
10. Sarih M, Bouchrit N, Bebslimane A. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol Lett 2000;74:117-20.
11. Sobue S, Nomura T, Ishikawa T, Ito S, Saso K, Ohara H, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001;36:544-51. (Pubitemid 32791841)
12. Yamaki K, Uchida H, Li X, Yanagisawa R, Takano H, Hayashi H, et al. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int J Immunopathol Pharmacol 2005;18:133-44. (Pubitemid 40343466)
13. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20. (Pubitemid 24196485)
14. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-93. (Pubitemid 26260021)
15. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of Hepatitis C Virus in Egypt. Lancet 2000;355:887-91. (Pubitemid 30137669)
16. Masmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57. (Pubitemid 16136806)
17. Gioia C, Horejsh D, Agrati C, Martini F, Capobianchi MR, Ippolito G, et al. T-Cell response profiling to biological threat agents including the SARS coronavirus. Int J Immunopathol Pharmacol 2005;18:525-30. (Pubitemid 41532367)
18. Lanzilli G, Falchetti R, Tricarico M, Ungheri D, Fuggetta MP. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol 2005;18: 245-54. (Pubitemid 40825887)
19. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-81. (Pubitemid 24353909)
20. Vecchiet J, Dalessandro M, Travasi F, Falasca K, Di Iorio A, Schiavone C, et al. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by anti-retroviral therapy. Int J Immunopathol Pharmacol 2003;16:157-66. (Pubitemid 36850856)
21. Perrella A, Borgia G, Borrelli F, Di Sirio S, Gnarini M, Grattacaso S, et al. TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. Int J Immunopathol Pharmacol 2005;18:189-93.
22. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, et al. Serun levels of cytokynes in chronic liver diseases. Gastroenterology 1992;103:264-74.
23. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post-treatment with interferon alfa. Hepatology 1996;24:6-9. (Pubitemid 26249404)
24. Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responser in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis 2004;189:1140-50. (Pubitemid 38457236)
25. Gonzalez-Peralta RP, Fang JW, Davis GL, Gish R, Tsukiyama- Kohara K, Kohara M, et al. Optimization for the detection of hepatitis C virus antigens in the liver. J Hepatol 1994;20:143-7. (Pubitemid 24043100)
26. Makris M, Preston FE, Ralph S. Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: A possible indicator of liver disease severity. Br J Haematol 1994;87:419-21. (Pubitemid 24204754)
27. Bozkaya H, Bozdayi AM, Aslan N, Türkay C, Sarioglu M, Cetinkaya H, et al. Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment. Infection 2000;28:309-13.
28. Gramenzi A, Andreone P, Loggi E, Foschi FG, Cursaro C, Margotti M, et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat 2005;12:525-30. (Pubitemid 41224258)
29. Paul WE. Interleukin. A prototypic immunoregulatory lymphokine. Blood 1991;77;1859-70.
30. Bahri A, Abdullah C, Hikmet A. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection. Turk J Gastroenterol 2003;14:7-11.
31. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis 1999;2: 157-68.
32. Gramenzi A, Andreone P, Loggi E, Foschi FG, Cursaro C, Margotti M, et al. Cytokine profile of peripheral blood mononuclear cell from patients with different outcomes of hepatitis C virus infection. J Viral Hepat 2005;12:525-30. (Pubitemid 41224258)
33. Kempuraj D, Donelan J, Frydas S, Iezzi T, Conti F, Boucher W, et al. Interleukin-28 and 29 (IL-28 and IL-29): New cytokines with anti-viral activities. Int J Immunopathol Pharmacol 2004;17:103-6. (Pubitemid 39572165)
34. Petrarca C, Frydas S, Donelan J, Boucher W, Papadopoulou N, Cao J, et al. Interleukin 27 (IL-27): A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int J Immunopathol Pharmacol 2005;18:191-4. (Pubitemid 40825881)
35. Huang SH, Frydas S, Conti P, Kempuraj D, Barbacane RC, Grilli A, et al. Interleukin-17: A revisited study. Int J Immunopathol Pharmacol 2004;17:1-4. (Pubitemid 39572181)
36. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254:279-82. (Pubitemid 21917341)
37. Mosmann TR, Subash S. The expanding universe of T cell subsets. Th1, Th2 and more. Immunol Today 1996;17:138-46.
38. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, et al. Role of T-cell derived cytokines in the down regulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992;127:183-204.
39. Scott P, Kaufmann SH. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
40. Ada GL, Blanden RV. Immunity and cytokine regulation in viral infection. Res Immunol 1994;145:625-9.
41. Del Prete G, Maggi E, Romagnani S. Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in diseases. Lab Invest 1994;70:299-306. (Pubitemid 24116523)
42. Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon ? increases the frequency of interferon gamma-producing CD4+ T Cells. J Exp Med 1993;178:1655-62.
43. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, et al. IL-4 and IFN-gamma exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992;149:2977-83.